Electroconvulsive therapy remains one of psychiatry's most effective interventions for severe illness — and one of its most misunderstood. For anyone facing ECT questions in exams or a real referral, knowing the side effects and contraindications of ECT matters twice: to judge when ECT is genuinely indicated, and to counsel patients accurately about risk.
This article covers what ECT does, who it's best for, the side-effect profile with a practical table, and the contraindication framework — separating genuine absolute exclusions from the relative risks that anaesthetic assessment actually weighs.
What ECT does, briefly
ECT passes a controlled electrical current across the scalp under general anaesthesia and muscle relaxation, inducing a generalised seizure (typically 20–60 seconds). The seizure is the therapeutic event; exact mechanisms remain debated but involve neuromodulation of monoaminergic and hypothalamic-pituitary circuits, neurotrophic effects, and normalisation of stress-axis hyperactivity. Modern forms are ultra-brief pulse or brief pulse bilateral/frontotemporal — markedly more targeted than historical sine-wave stimuli, which is why cognitive side effects have fallen substantially.
When ECT is the preferred option
NICE guidance positions ECT for severe, life-threatening depression (or mania) where there is an urgent need for rapid response — rapid response is itself a core indication. Strong evidence-based scenarios include:
- Severe depression with catatonia, including malignant catatonia
- Depression during pregnancy where medication is ineffective or contraindicated
- Refusal of food and fluids in severe depression (a medical emergency)
- Prior excellent response to ECT with current episode non-responsive to medication
- Severe depression with high suicide risk needing rapid stabilisation
Side effects: what patients actually experience
ECT is among the safest procedures in medicine — mortality comparable to other anaesthetised procedures — but adverse effects cluster around three systems: cognitive, neurological and anaesthetic.
| Side effect | Timing | Notes and management |
|---|---|---|
| Retrograde amnesia | During and after course | Most common; pre-ECT autobiographical memories worst, usually recovers over weeks–months |
| Anterograde confusion | Minutes–hours post-ictal | Resolve same day in most patients; longer in older adults |
| Headache | After session | Common, analgesia-responsive; may recur pre-session |
| Nausea/vomiting | Post-ictal | Antiemetic given with anaesthetic |
| Muscle aches/jaw pain | Day of treatment | Adequate muscle relaxation prevents true injury |
| Prolonged seizure (rare) | During session | Managed by anaesthetic, threshold adjustment or anticonvulsant |
| Cardiac arrhythmia (rare) | Peri-ictal | Brief vagal/pressor response; continuous ECG monitoring standard |
| Transient confusion/long-term memory change | After course | Usually resolves by 1–3 months; risk increases with bilateral placement and age |
Contraindications: absolute versus relative
True absolute contraindications are few: recent intracerebral haemorrhage or raised intracranial pressure from mass lesion, phaeochromocytoma (hypertensive crisis risk), and aortic/cerebral aneurysm — most entities are relative and weighed against the illness severity. Classically cited relative contraindications include recent myocardial infarction, unstable cardiac disease, severe pulmonary disease, and difficult airway anatomy.
The key conceptual point examiners test: ECT's risks are anaesthetic risks in a population whose psychiatric illness (refusal of treatment, malnutrition, medical neglect) may itself be more dangerous than the procedure. Modern ECT requires anaesthetic and medical fitness assessment, and guidance evolves — always check the current Royal College and NICE/Association position for exact lists.
Cognitive effects in perspective
Cognitive assessment (e.g., the Squire Subjective Memory Questionnaire, or semi-structured cognitive interviews) consistently shows: autobiographical memory gaps for the pre-ECT period, temporary orientation problems immediately post-session, and — crucially — improvement in depression-related cognitive deficits (psychomotor slowing, poor concentration) as the mood episode lifts. Patients often over-attribute forgetting to ECT when the alternative was untreated depression.
High-yield
Two exam anchors. First: ECT is not contraindicated in pregnancy — it's often the safest rapid option with abdominal shielding. Second: the most cited cognitive risk factor is bilateral electrode placement in older patients, and retrograde amnesia — not the seizure itself — dominates the side-effect profile. If an MCQ offers "contraindicated in pregnancy" or "causes permanent brain damage", both are wrong.
What an ECT course actually looks like
Modern ECT is delivered as a planned course, typically 6–12 sessions given two to three times per week, with the number of treatments individualised by response — the historical "six, then reassess" heuristic has given way to response-guided continuation. Each session follows the same sequence: pre-anaesthetic check (including consent confirmation and pregnancy status where applicable), intravenous access, anaesthetic induction with a muscle relaxant, pre-treatment with an anticholinergic if indicated, stimulus delivery with EEG and ECG monitoring, and recovery in a supervised bay until orientation returns.
Seizure quality is monitored on EEG — duration and motor correlate — because inadequate seizures reduce efficacy; stimulus dose is titrated upward when seizure adequacy falls short. Right unilateral or bilateral electrode placement is selected per illness features and cognitive risk, with ultra-brief pulse waveforms preferred where available.
After the acute course, the continuation question matters: relapse rates after ECT without continuation treatment are substantial, particularly in recurrent severe depression. Practice combines continuation antidepressant or mood-stabilising pharmacotherapy — chosen with attention to prior response — and, in selected high-risk cases, maintenance ECT at tapering intervals. The cognitive side of the ledger is rechecked at each visit: memory complaints should be tracked explicitly rather than assumed, and the plan adjusted (placement, pulse width, session interval) when they persist.
Consent deserves its own emphasis: capacity to consent to ECT is assessed and documented specifically — the illness itself can impair capacity by stripping the patient of hope, and fluctuating capacity in severe depression is common. Where a patient lacks capacity, legal frameworks for treatment in their best interests apply, with second opinions as required by jurisdiction. Framing ECT accurately in that conversation — realistic benefits, realistic cognitive risks, honest uncertainty about mechanism — supports decisions that patients and families can live with afterwards.
For exam revisions, hold the three anchors together: urgency of indication, anaesthetic fitness, and cognitive risk profile — everything else in an ECT question is detail hung off those hooks.
Frequently asked questions
What are the most common side effects of ECT?
Headache, nausea, temporary confusion and — most importantly — retrograde amnesia for events before the treatment course. Memory complaints usually improve markedly within weeks to three months, and objective concentration often improves as the depression itself lifts.
Is ECT contraindicated in pregnancy?
No. With obstetric coordination, general anaesthesia and fetal monitoring plus abdominal shielding, ECT is a recognised option in pregnancy for severe depression, particularly when medication is ineffective or the illness is life-threatening. Historic blanket contraindications are obsolete.
What are the absolute contraindications to ECT?
True absolutes are limited: conditions with severely raised intracranial pressure such as intracranial mass or recent intracerebral haemorrhage, phaeochromocytoma, and unstable aneurysmal disease. Most other conditions — recent myocardial infarction, cardiac or pulmonary disease — are relative and weighed against the urgency of the psychiatric illness.
Does ECT cause permanent memory loss?
Most cognitive effects are transient, resolving over days to three months. A minority of patients report persistent autobiographical gaps, particularly after bilateral placement. Modern ultra-brief pulse techniques, right unilateral placement and electrode titration substantially reduce this risk.
Key takeaways
- ECT works by inducing a generalised seizure under anaesthesia; ultra-brief/brief pulse replaced old sine-wave stimulus.
- Best indications: severe life-threatening depression with urgent need — catatonia, pregnancy, food/fluid refusal, high suicide risk.
- Side-effect profile: retrograde amnesia (most important), post-ictal confusion, headache, nausea — all usually transient.
- Absolutes are few (raised ICP, phaeochromocytoma); most risks are relative anaesthetic risks weighed against illness severity.
- Bilateral placement + older age = highest cognitive risk; pregnancy is not a contraindication.
Consolidate the ECT indications and risk framework in Preppsy's concept library — then test yourself on the treatment menu under exam conditions.
Cover image: “ECT: Effects and Risks (cover)” by Preppsy Editorial Team (Original artwork) via Preppsy.
